Korro Bio, Inc. Balance Sheet
KRRO|6 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Korro Bio, Inc. had $114M in total assets and $160M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $21.8M | $36.6M | $52.0M | $79.6M | $220.3M | $200.2M |
| Current Assets | $82.4M | $131.5M | $87.5M | $134.7M | $225.1M | $221.4M |
| PP&E (Net) | $8.2M | $27.7M | $2.7M | $5.5M | $7.3M | $1.8M |
| Total Assets | $113.5M | $226.2M | $121.2M | $185.4M | $264.7M | $223.2M |
| Current Liabilities | $11.9M | $15.0M | $21.0M | $11.4M | $26.6M | $52.8M |
| Total Debt | - | - | - | - | - | $180.0K |
| Shareholders' Equity | $160.4M | $169.9M | $130.8M | $192.5M | $167.4M | -$48.3M |